Healx
2019
Series B
Biotechnology
Raised $56,000,000
Industry
Biotechnology
Stage
Series B
Raised
$56,000,000
Company Overview
Healx Limited operates as a biotechnology company. The Company develops pharmaceutical products to find new therapeutic solutions for patients with rare diseases. Healx serves patients in the United Kingdom.
Business Model
Subscription
Customer Model
B2G, B2B
Pitch Deck
Market Opportunity
Discover the market opportunity in the Biotechnology industry. Learn about market size, growth potential, and competitive landscape.
Explore Market Research →Similar Companies
View pitch decks from other series b companies in the Biotechnology industry.
View Similar Pitch Decks →Resources & Tips
Pitch Deck Best Practices
Learn how to create an effective pitch deck that resonates with investors.
Read Guide →